Allison M Fowler
Overview
Explore the profile of Allison M Fowler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stavrou M, Kagiava A, Choudury S, Jennings M, Wallace L, Fowler A, et al.
J Clin Invest
. 2022 May;
132(13).
PMID: 35579942
Charcot-Marie-Tooth disease type 1A (CMT1A), the most common inherited demyelinating peripheral neuropathy, is caused by PMP22 gene duplication. Overexpression of WT PMP22 in Schwann cells destabilizes the myelin sheath, leading...
2.
Aimiuwu O, Fowler A, Sah M, Teoh J, Kanber A, Pyne N, et al.
Mol Ther
. 2020 May;
28(7):1706-1716.
PMID: 32353324
Developmental and epileptic encephalopathy (DEE) associated with de novo variants in the gene encoding dynamin-1 (DNM1) is a severe debilitating disease with no pharmacological remedy. Like most genetic DEEs, the...
3.
Morelli K, Griffin L, Pyne N, Wallace L, Fowler A, Oprescu S, et al.
J Clin Invest
. 2019 Sep;
129(12):5568-5583.
PMID: 31557132
Gene therapy approaches are being deployed to treat recessive genetic disorders by restoring the expression of mutated genes. However, the feasibility of these approaches for dominantly inherited diseases - where...
4.
Giesige C, Wallace L, Heller K, Eidahl J, Saad N, Fowler A, et al.
JCI Insight
. 2018 Nov;
3(22).
PMID: 30429376
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant or digenic disorder linked to derepression of the toxic DUX4 gene in muscle. There is currently no pharmacological treatment. The emergence of...
5.
Wallace L, Saad N, Pyne N, Fowler A, Eidahl J, Domire J, et al.
Mol Ther Methods Clin Dev
. 2018 Feb;
8:121-130.
PMID: 29387734
RNAi emerged as a prospective molecular therapy nearly 15 years ago. Since then, two major RNAi platforms have been under development: oligonucleotides and gene therapy. Oligonucleotide-based approaches have seen more...
6.
Eidahl J, Giesige C, Domire J, Wallace L, Fowler A, Guckes S, et al.
Hum Mol Genet
. 2017 Feb;
25(20):4577-4589.
PMID: 28173143
D4Z4 repeats are present in at least 11 different mammalian species, including humans and mice. Each repeat contains an open reading frame encoding a double homeodomain (DUX) family transcription factor....